OTCMKTS:MEOBF Mesoblast (MEOBF) News Today $0.35 -0.50 (-58.82%) (As of 08/4/2023) Add Compare Share Share Today's Range$0.35▼$0.3550-Day Range$0.35▼$1.0052-Week Range$0.35▼$1.00Volume2,000 shsAverage Volume1,950 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMesoblast Limited (MEOBF) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - January 11 at 6:24 PMMESO.O - Mesoblast limited (ADR) | Stock Price & Latest News | Reutersreuters.com - September 29 at 9:39 PMMesoblast Teva Startsinvesting.com - September 29 at 4:34 PMMesoblast Limited (MESO) Q4 2022 Earnings Call Transcriptseekingalpha.com - September 1 at 11:18 PMMesoblast Limited 2022 Q4 - Results - Earnings Call Presentationseekingalpha.com - September 1 at 11:18 PMMindMed Appoints Schond L. Greenway As CFOmarkets.businessinsider.com - May 25 at 9:37 AMMesoblast (OTC:MEOBF), Short Interest Reportbenzinga.com - May 25 at 9:37 AMMesoblast (OTC:MEOBF), Earnings Estimates, EPS, and Revenuebenzinga.com - May 25 at 9:37 AMMesoblast reports FQ3 resultsseekingalpha.com - April 29 at 7:22 AMMesoblast Limited (MESO) Q1 2022 Earnings Call Transcriptfool.com - March 28 at 10:10 PMWhy Mesoblast Stock Is Plunging After Q4 Earnings Report?markets.businessinsider.com - August 31 at 12:26 PMLoss-Making Mesoblast Limited (ASX:MSB) Expected To Breakeven In The Medium-Termfinance.yahoo.com - August 24 at 10:19 PMMesoblast Shares 90-Day Survival Outcomes After Remestemcel-L From COVID-19 ARDS Trialfinance.yahoo.com - July 19 at 1:18 PMNinety Day Survival Outcomes in COVID-19 ARDS Trial of Remestemcel-L Presented at ISCT Meeting on Advances in Cell & Gene Therapies for Lung Diseasesbenzinga.com - July 18 at 9:04 PMMesoblast Presents Respiratory Function Results of COVID-19 ARDS Trial at Pulmonary Disease Conferencefinance.yahoo.com - July 15 at 11:30 PMMesoblast Updates On Rexlemestrocel-L Program In Chronic Low Back Painfinance.yahoo.com - July 1 at 12:45 PMMesoblast Provides Update on Program for Chronic Low Back Pain Due to Degenerative Disc Diseasefinance.yahoo.com - June 30 at 8:22 PMIs Mesoblast (ASX:MSB) Using Debt Sensibly?finance.yahoo.com - June 25 at 8:11 PMOperational Highlights and Financial Results for the Period Ended March 31, 2021finance.yahoo.com - June 2 at 9:06 PM Mesoblast Corporate Update and Financial Results Webcastmarkets.businessinsider.com - June 2 at 6:27 PMImproved Outcomes in Inflammatory Lung Disease With Remestemcel-L Published in Respiratory Research Journalfinance.yahoo.com - May 25 at 7:19 AMStrength Seen in Mesoblast Limited (MESO): Can Its 6.1% Jump Turn into More Strength?finance.yahoo.com - May 3 at 2:01 PMMesoblast Shares Rise As Remestemcel-L Cuts Mortality In Patients Below 65 Years With COVID-19 Related Respiratory Distressfeeds.benzinga.com - April 30 at 10:27 AMMesoblast Operational Highlights and Upcoming Milestonesfinance.yahoo.com - March 30 at 9:52 PMPhilip J. Facchina, Chief Strategy Officer and Principal of SurgCenter Development, Joins Mesoblast Boardfinance.yahoo.com - March 29 at 9:24 AMMesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chronic Low Back Pain Due to Degenerative Disc Diseasefinance.yahoo.com - February 10 at 7:34 PMMesoblast Operational and Financial Highlights for Quarter Ended December 31, 2020finance.yahoo.com - January 28 at 7:18 PMWhy Mesoblast Stock Skyrocketed Todayfinance.yahoo.com - January 11 at 5:07 PMSingle Dose of Rexlemestrocel-L Provides Substantial and Durable Reduction in Heart Attacks, Strokes and Cardiac Death in Patients With Chronic Heart Failurefinance.yahoo.com - January 11 at 2:05 AMWhy Mesoblast Stock Plummeted on Fridayfinance.yahoo.com - December 18 at 6:50 PMMesoblast Webcast – Update on COVID-19 ARDS Trialfinance.yahoo.com - December 17 at 10:35 PMWhy Mesoblast Stock Is Tanking Todayfinance.yahoo.com - December 15 at 1:27 PMLawsuit for Investors in shares of Mesoblast Limited (OTC: MEOBF) announced by Shareholders Foundationfinance.yahoo.com - December 8 at 9:03 AMFINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firmfinance.yahoo.com - December 7 at 2:28 AMMESO FINAL MONDAY DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mesoblast Limited Investors Seek Counsel Before Important December 7 Deadline in Securities Class Action – MESOfinance.yahoo.com - December 6 at 4:27 PMThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of MESO, LOOP and TILEfinance.yahoo.com - November 30 at 4:26 PMAnalysts Just Made A Stunning Upgrade To Their Mesoblast Limited (ASX:MSB) Forecastsfinance.yahoo.com - November 26 at 3:51 PMCLASS ACTION UPDATE for MESO, LOOP and BIIB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholdersfinance.yahoo.com - November 25 at 12:40 PMBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Royal Caribbean, Mesoblast, Loop Industries, and Turquoise Hill Resources and Encourages Investors to Contact the Firmfinance.yahoo.com - November 24 at 4:37 PMSHAREHOLDER ALERT: MESO FAF LRN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlinesfinance.yahoo.com - November 24 at 6:35 AMLAWSUITS FILED AGAINST NXTC, MESO and LVS - Jakubowitz Law Pursues Shareholders Claimsfinance.yahoo.com - November 18 at 6:18 PMMESO LOSS ALERT: LONGSTANDING AND LEADING ROSEN LAW FIRM, Encourages Mesoblast Limited Investors With Large Losses Contact Firm before Important Deadline in Securities Class Action - MESOfinance.yahoo.com - November 13 at 1:59 PMRosen, National Trial Counsel, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action - MESOfinance.yahoo.com - November 11 at 5:35 PMLAWSUITS FILED AGAINST GOCO, MESO and ZSAN - Jakubowitz Law Pursues Shareholders Claimsfinance.yahoo.com - November 11 at 12:34 PMSecond Interim Analysis of Clinical Outcomes After 135 Patients Results in Recommendation to Continue Remestemcel-L Phase 3 Trial in COVID-19 ARDSfinance.yahoo.com - November 11 at 7:34 AMLawsuits Filed Against GLNG, RCL and MESO - Jakubowitz Law Pursues Shareholders Claimsfinance.yahoo.com - November 10 at 5:29 PMDEADLINE ALERT for RCL, MESO, LOOP, TRQ: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholdersfinance.yahoo.com - November 10 at 12:28 PMSHAREHOLDER ALERT: C RCL MESO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlinesfinance.yahoo.com - November 10 at 7:28 AMRosen, Top Ranked Investor Counsel, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action - MESOfinance.yahoo.com - November 6 at 7:23 PMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mesoblast Limited of Class Action Law Suit and Upcoming Deadline – MESOfinance.yahoo.com - November 4 at 10:13 PM Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MEOBF and its competitors with MarketBeat's FREE daily newsletter. Email Address MEOBF Media Mentions By Week MEOBF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEOBF News Sentiment▼-1.000.59▲Average Medical News Sentiment MEOBF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEOBF Articles This Week▼10▲MEOBF Articles Average Week Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MEOBF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Agentix News Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Apexigen News Arno Therapeutics News Ascletis Pharma News Avacta Group News Awakn Life Sciences News AXIM Biotechnologies News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (OTCMKTS:MEOBF) was last updated on 8/14/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.